BSE Live
Jan 23, 16:01Prev. Close
4055.60
Open Price
4055.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:55Prev. Close
4055.30
Open Price
4055.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Sanofi India (in Rs. Cr.) | Dec 04 | |
| Per Share Ratios | ||
| Basic EPS (Rs.) | 64.48 | |
| Diluted EPS (Rs.) | 64.48 | |
| Cash EPS (Rs.) | 71.79 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 175.43 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 183.16 | |
| Dividend / Share(Rs.) | 16.00 | |
| Revenue from Operations/Share (Rs.) | 319.17 | |
| PBDIT/Share (Rs.) | 105.55 | |
| PBIT/Share (Rs.) | 98.24 | |
| PBT/Share (Rs.) | 98.20 | |
| Net Profit/Share (Rs.) | 64.48 | |
| Profitability Ratios | ||
| PBDIT Margin (%) | 33.07 | |
| PBIT Margin (%) | 30.78 | |
| PBT Margin (%) | 30.76 | |
| Net Profit Margin (%) | 20.20 | |
| Return on Networth / Equity (%) | 36.75 | |
| Return on Capital Employed (%) | 33.63 | |
| Return on Assets (%) | 25.98 | |
| Total Debt/Equity (X) | 0.05 | |
| Asset Turnover Ratio (%) | 128.63 | |
| Liquidity Ratios | ||
| Current Ratio (X) | 3.16 | |
| Quick Ratio (X) | 2.38 | |
| Inventory Turnover Ratio (X) | 7.23 | |
| Dividend Payout Ratio (NP) (%) | 24.81 | |
| Dividend Payout Ratio (CP) (%) | 22.28 | |
| Earnings Retention Ratio (%) | 75.19 | |
| Cash Earnings Retention Ratio (%) | 77.72 | |
| Valuation Ratios | ||
| Enterprise Value (Cr.) | 2,894.41 | |
| EV/Net Operating Revenue (X) | 3.94 | |
| EV/EBITDA (X) | 11.91 | |
| MarketCap/Net Operating Revenue (X) | 4.14 | |
| Retention Ratios (%) | 75.18 | |
| Price/BV (X) | 7.53 | |
| Price/Net Operating Revenue | 4.14 | |
| Earnings Yield | 0.05 |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y